Search
Close this search box.

July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment

GIZ hands over vehicles, equipment to Employment Ministry

Gesellschaft fr Internationale Zusammenarbeit (GIZ), with the European Union (EU) through the joint action for Jobs, Migration and Development, is supporting the Labour Department of the Ministry of Employment and Labour Relations, with five pick-up v…

Chief Justice declares July 15 to 19 as ADR Week

Justice Mrs Gertrude Sackey Torkornoo, the Chief Justice, has declared 15 to 19 July 2024 as Alternative Dispute Resolution (ADR) week nationwide.

It would be the second of the three series observed thrice yearly, apart from March and November.

In a…

NASPA has not declared any strike

The National Service Personnel Association (NASPA), the official representative body of national service personnel, says the Association has not declared any strike.

NASPA is, therefore, urging the public to disregard the statement from a group calli…

CLOGSAG strike: NRCC offices closed

Offices at the Northern Regional Coordinating Council (NRCC) have been closed due to a nationwide strike initiated by members of the Civil and Local Government Staff Association of Ghana (CLOGSAG).

When the Ghana News Agency visited the Regional Budg…